Consistent with these findings, we found that USP4 knockdown in lung cancer cells increased phosphorylation of RelA, which is essential for NF-κB activation, and enhanced both basal and stimulus-induced inflammatory cytokine production, including production evoked by TNF-α and TLR ligands. Here, USP4 is linked to lung carcinoma.